Weekly Stream
Advertisement
TAG shows promise for BPDCN patients under 50, reducing toxicity and enabling safer transplants.
Experts debate immune escape, inflammation, and early intervention in relapsed/refractory multiple myeloma.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.